Alliance Pharma plc (APH.L)

GBp 64.6

(0.16%)

EBITDA Summary of Alliance Pharma plc

  • Alliance Pharma plc's latest annual EBITDA in 2023 was -28.94 Million GBP , up 116.78% from previous year.
  • Alliance Pharma plc's latest quarterly EBITDA in 2024 Q2 was 15.71 Million GBP , down 0.0% from previous quarter.
  • Alliance Pharma plc reported an annual EBITDA of -6.85 Million GBP in 2022, down -52.37% from previous year.
  • Alliance Pharma plc reported an annual EBITDA of 31.9 Million GBP in 2021, down -9.45% from previous year.
  • Alliance Pharma plc reported a quarterly EBITDA of 34.17 Million GBP for 2023 Q4, down 0.0% from previous quarter.
  • Alliance Pharma plc reported a quarterly EBITDA of N/A for 2023 FY, up 116.78% from previous quarter.

Annual EBITDA Chart of Alliance Pharma plc (2023 - 1998)

Historical Annual EBITDA of Alliance Pharma plc (2023 - 1998)

Year EBITDA EBITDA Growth
2023 -28.94 Million GBP 116.78%
2022 -6.85 Million GBP -52.37%
2021 31.9 Million GBP -9.45%
2020 24.58 Million GBP 26.16%
2019 36.52 Million GBP -1.96%
2018 27.75 Million GBP 40.4%
2017 32.75 Million GBP 4.61%
2016 25.57 Million GBP 108.1%
2015 16.64 Million GBP -3.45%
2014 12.56 Million GBP -5.55%
2013 13.98 Million GBP 5.96%
2012 13.19 Million GBP 0.05%
2011 13.27 Million GBP -31.68%
2010 16.06 Million GBP 69.2%
2009 8.55 Million GBP 102.81%
2008 5.64 Million GBP 76.41%
2007 -213 Thousand GBP 19.98%
2006 2.65 Million GBP 30.56%
2005 2.31 Million GBP -23.26%
2004 2.43 Million GBP 4.37%
2003 225 Thousand GBP 3700.17%
2002 1.86 Million GBP -108.48%
2001 672 Thousand GBP 98.8%
2000 418 Thousand GBP 1.7%
1999 411 Thousand GBP 228.8%
1998 125 Thousand GBP 0.0%

Peer EBITDA Comparison of Alliance Pharma plc

Name EBITDA EBITDA Difference